Quantitative structure-activity relationships of perfluorinated hetero- hydrocarbons as potential respiratory media: Application to oxygen solubility, partition coefficient, viscosity, vapor pressure, and density

ASAIO Journal

Volumn 42, Issue 6, 1996, Pages 968-973

  Gabriel, Jerome L ^a   Miller Jr , T F ^a   Wolfson, Marla R ^a   Shaffer, Thomas H ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHMS; BIOCOMPATIBILITY; DATABASE SYSTEMS; DENSITY (SPECIFIC GRAVITY); FLUOROCARBONS; OXYGEN; RESPIRATORY MECHANICS; RESPIRATORY THERAPY; SOLUBILITY; SURFACE TENSION; VAPOR PRESSURE; VISCOSITY OF LIQUIDS;

PERFLUOROCARBON LIQUIDS;

BIOMATERIALS;

FLUOROCARBON;

ARTICLE; GAS EXCHANGE; MATHEMATICAL ANALYSIS; OXYGEN DIFFUSION; PARTITION COEFFICIENT; PERMEABILITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VISCOSITY;

EID: 0030297504     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199642060-00009     Document Type: Article

References (44)

1. Nabih M, Peyman G, Clark LC, et al: Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: a preliminary report. Opthalmic Surg 20: 286-293, 1989.
2. Liu MS, Long DM: Biological disposition of perfluöroctylbromide: tracheal administration on alveolography and bronchography. Invest Radiol 11: 479-485, 1976.
3. Mattrey RF: Perfluorooctylbromide: a new contrast agent for CT, sonography and MR Imaging. AJR Am J Roentgenol 152: 247-252, 1989.
4. Stern RG, Wolfson MR, McGuckin JF, Forge JA, Shaffer TH: High-resolution computed tomographic bronchiolography using perfluoroctylbromide (PFOB): an experimental model. J Thorac Imaging 8: 300-304, 1993.
5. Modell JH, Newby EJ, Ruiz BC: Long-term survival of dogs after breathing oxygenated fluorocarbon liquid. Fed Proc 29: 1731-1736, 1970.
6. Clark LC Jr, Ackerman JL, Thomas SR, et al: Perfluorinated organic liquid and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygen, in Riess J, Winslow RM (eds), New York, Marcel Dekker, 1985, pp. 835-845.
7. Riess JG, LeBlanc M: Solubility and transport phenomenon in perfluorochemical relevant to blood substitution and other biomedical applications. Pure Applied Chemistry 54: 2383-2406, 1982.
8. Riess JG: Overview of progress in the fluorocarbon approach to in vivo oxygen delivery (Review). Artif Cells Blood Substit Immobil Biotechnol xx: 20-24, 1992.
9. Riess JC: Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships. Artif Organs 8: 44-56, 1984.
10. Clark LC Jr, Wessler EP, Kaplan S, et al: Emulsions of perfluorinated solvents for intravascular gas transport. Fed Proc 34: 1468-1477, 1975.
11. Clark LC Jr, Wassailer EP, Miller ML, Kaplan S: Ring versus straight chain perfluorocarbon emulsions for perfusion media. Microvasc Res 8: 320-340, 1974.
12. Wolfson MR, Greenspan JS, Deoras KS, Rubenstein SD, Shaffer TH: Comparison of gas and liquid ventilation: clinical, physiological, and histological correlates. J Appl Physiol 72: 1024-1031, 1992.
13. Shaffer TH, Wolfson MR, Clark LC: Liquid ventilation (Review). Pediatr Pulmonol 14: 102-109, 1992.
14. Calderwood HW, Ruiz BC, Tham MK, Modell JH, Saga S, Hood CI: Residual levels and biochemical changes after ventilation with perfluorinated liquid. J Appl Physiol 39: 603-607, 1975.
15. Clark LC Jr, Gollan F: Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152: 1755-1756, 1966.
16. Holaday DA, Fiserova-Bergerova V, Modell JH: Uptake, distribution, and excretion of fluorocarbon FX-80 (perfluorobutyl perfluorotetrahydrofuran) during liquid breathing in the dog. Anesthesiology 37: 387-394, 1972.
17. Modell JH, Tham MK, Calderwood HW, Ruiz BC: Distribution and retention of fluorocarbon in mice and dogs after injection or liquid ventilation. Toxicol Appl Pharmacol 26: 86-92, 1973.
18. Clark LC Jr, Hoffman RE, Davis SL: Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 20: 1085-1099, 1992.
19. Kelly C, Mathias P, Schweighardt F: Correlating vapor pressures of perfluorinated saturated hydrocarbons by a group contribution method. I&EC Research 27: 1732-1736, 1988.
20. Wessler EP, Iltis R, Clark LC Jr: The solubility of oxygen in highly fluorinated liquids. Journal of Fluorine Chemistry 9: 137-146, 1977.
21. Tham MK, Walker RD, Modell JH: Physical properties and gas solubilities in selected fluorinated ethers. Journal of Chemical Engineering Data 18: 385-386, 1973.
22. Clark LC Jr: Introduction to fluorocarbons. Int Anaesthesiol Clin 23: 1-10, 1985.
23. Moore RE, Clark LC Jr: Chemistry of fluorocarbons in biomedical use. Int Anaesthesiol Clin 23: 11-24, 1985.
24. Argent JW, Seffl RJ: Properties of perfluorinated liquid. Fed Proc 29: 1699-1703, 1970.
25. Hansch C, Fujita T: A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society 86: 1616-1626, 1964.
26. Rekker RF: The hydrophobic fragmental constant; an extension to a 1000 data point set. European Journal of Medical Chemistry 14: 479-488, 1979.
27. Wiener H: Structural determination of paraffin boiling points. Journal of the American Chemical Society 69: 17-20, 1947.
28. Needham DE, Wei I, Seybold P: Molecular modeling of the physical properties of the alkanes. tournal of the American Chemical Society 110:4186-4194, 1988.
29. Randic' M: On characterization of molecular branching Journal of the American Chemical Society 97: 6609-6615, 1975.
30. Dennis J, Gay DM, Welsch RE: An adaptive non-linear least squares algorithm. ACM Trans on Math Software 7: 3-7, 1981.
31. Wolfson MR, Tran N, Bhutani VK, Shaffer TH: A new experimental approach for the study of cardiopulmonary physiology during early development. J Appl Physiol 65:1436-1443, 1988.
32. Wolfson MR, Shaffer TH: Liquid ventilation during early development: theory, physiologic processes and application. J Dev Physiol 13: 1-12, 1990.
33. Shaffer TH, Moskowitz GD: Demand-controlled liquid ventilation of the lungs. J Appl Physiol 36: 208-213, 1974.
34. Shaffer TH, Tran N, Bhutani VK, Sivieri EM: Cardiopulmonary function in very preterm lambs during liquid ventilation. Pediatr Res 17: 680-684, 1983.
35. Shaffer TH: A brief review: liquid ventilation. Undersea Biomedical Research 14: 169-178, 1987.
36. Rufer R, Spitzer HL: Liquid ventilation in the respiratory distress syndrome. Chest 66: 29S-30S, 1974.
37. Greenspan JS, Wolfson MR, Rubenstein SD, Shaffer TH: Liquid ventilation of preterm baby (Letter). Lancet Nov(4): 1095, 1989.
38. Greenspan JS, Wolfson MR, Rubenstein SD, Shaffer TH: Liquid ventilation of human preterm neonates. J Pediatr 117: 106-111, 1990.
39. Leach CL, Greenspan JS, Rubenstein SD, et al: Partial liquid ventilation with LiquiVent: a pilot and safety and efficacy study in premature newborns with severe respiratory distress syndrome (RDS). Pediatr Res 37: 220, 1995.
40. Richman PS, Wolfson MR, Shaffer TH: Lung lavage with oxygenated perfluorochemical liquid in acute lung injury. Crit Care Med 21: 768-774, 1993.
41. Tutuncu AS, Faithfull NS, Lachmann B: Comparison of ventilatory support with intratracheal perfluorocarbon administration and conventional mechanical ventilation in animals with acute respiratory failure. American Review of Respiratory Disease 148: 785-792, 1993.
42. Wolfson MR, Kechner NE, Frisss HE, Rubenstein SD, Dechadrevian JP, Shaffer TH: Liquid assisted ventilation: dose and breathing frequency strategy in the immature lamb. Pediatr Res 37: 356, 1995.
43. Hirschl RB, Parent A, Tooley R, et al: Liquid ventilation improves pulmonary function, gas exchange, and lung injury in a model of respiratory failure. Ann Surg 221: 79-88, 1995.
44. Wolfson MR, Greenspan JS, Shaffer TH: Pulmonary administration of Priscoline (Pris) by perfluorochemical liquid ventilation: reversal of induced-pulmonary hypertension and hypoxemia. Pediatr Res 31 : A229, 1992.